FCRL4
Fc receptor-like protein 4
Also known as: CD307d, FCRH4, FCRL4_HUMAN, IGFP2, IRTA1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PJ5
- Gene
- FCRL4
- Ensembl
- ENSG00000163518
- Chromosome
- 1
- Canonical length
- 515 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein has four extracellular C2-type immunoglobulin domains, a transmembrane domain and a cytoplasmic domain that contains three immune-receptor tyrosine-based inhibitory motifs. This protein may play a role in the function of memory B-cells in the epithelia. Aberrations in the chromosomal region encoding this gene are associated with non-Hodgkin lymphoma and multiple myeloma. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
515 residues, UniProt reviewed canonical sequence.
>Q96PJ5|FCRL4
1 MLLWASLLAF APVCGQSAAA HKPVISVHPP WTTFFKGERV TLTCNGFQFY ATEKTTWYHR
61 HYWGEKLTLT PGNTLEVRES GLYRCQARGS PRSNPVRLLF SSDSLILQAP YSVFEGDTLV
121 LRCHRRRKEK LTAVKYTWNG NILSISNKSW DLLIPQASSN NNGNYRCIGY GDENDVFRSN
181 FKIIKIQELF PHPELKATDS QPTEGNSVNL SCETQLPPER SDTPLHFNFF RDGEVILSDW
241 STYPELQLPT VWRENSGSYW CGAETVRGNI HKHSPSLQIH VQRIPVSGVL LETQPSGGQA
301 VEGEMLVLVC SVAEGTGDTT FSWHREDMQE SLGRKTQRSL RAELELPAIR QSHAGGYYCT
361 ADNSYGPVQS MVLNVTVRET PGNRDGLVAA GATGGLLSAL LLAVALLFHC WRRRKSGVGF
421 LGDETRLPPA PGPGESSHSI CPAQVELQSL YVDVHPKKGD LVYSEIQTTQ LGEEEEANTS
481 RTLLEDKDVS VVYSEVKTQH PDNSAGKISS KDEESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FCRL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 9.8 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 9.8 nTPM
- lymph node: 3.5 nTPM
- appendix: 2.5 nTPM
- small intestine: 1.3 nTPM
- spleen: 0.8 nTPM
- rectum: 0.3 nTPM
Single-cell type
- nk-cells: 3.8 nCPM
- b-cells: 3.4 nCPM
- thymocytes: 3.4 nCPM
- goblet cells: 3.2 nCPM
- plasma cells: 1.6 nCPM
- gastric chief cells: 1.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- cerebellum: 0.1 nTPM
- midbrain: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.58
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FCRL4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FCRL4 as an antibody target. Whether an autoantibody or antibody against FCRL4 could matter depends on whether native FCRL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FCRL4 is annotated at the cell surface, where native FCRL4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FCRL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...